icd10free.comPowered by Curo

ICD-10 Coding for Infusion of Rituximab-abbs(M05.79, M05.7, M06.9)

Save

Learn about the ICD-10 coding and documentation requirements for the infusion of rituximab-abbs, including primary codes, billing considerations, and common pitfalls.

Also known as:
Rituximab-abbs infusionTruxima infusion
Related ICD-10 Code Ranges

Complete code families applicable to Infusion of Rituximab-abbs

M00-M99Primary Range

Diseases of the musculoskeletal system and connective tissue

→
Primary ICD-10-CM Codes
Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement
M05.79Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Rheumatoid arthritis, unspecifiedM06.9

Documentation & Coding Risks

Avoid these common issues when documenting Infusion of Rituximab-abbs.

Omitting premedication documentation

Impact

Clinical: Potential for adverse reactions without documented premedication., Regulatory: Non-compliance with infusion protocols., Financial: Denial of claims due to incomplete documentation.

Mitigation

Include premedication details in the infusion order, Verify documentation before submission

Using J9312 instead of Q5115 for rituximab-abbs

Impact

Reimbursement: Incorrect reimbursement due to wrong drug code., Compliance: Non-compliance with payer-specific coding requirements., Data Quality: Inaccurate data on drug utilization.

Mitigation

Verify the specific biosimilar used and code accordingly.

Drug Coding

Impact

Incorrect coding of biosimilar drugs.

Mitigation

Verify drug name and NDC before coding.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with M05.79.